There is increasing evidence that autoantibodies (AAbs) against oxidatively modified low-
density lipoprotein (LDL) are present in humans and may be detected in fasting plasma …

Objective Over 90% of modified LDL in circulation is associated to specific antibodies
circulating as part of immune complexes (IC); however, few studies have examined their …

Objective—Previous smaller studies have indicated inverse associations between
autoantibodies to oxidized low-density lipoprotein epitopes, and cardiovascular disease …

The role of the immune system in modulating atherosclerosis has recently been the subject
of intensive research. Several previous authors have put forward a paradigm of the …

Atherosclerosis is a disease characterized by chronic inflammation. Looking back it is almost
embarrassing how long it took for us to realize that the presence of these innate immune …

Atherosclerosis is the major cause of cardiovascular disease (CVD) and in addition to
established risk factors as smoking, hypertension, diabetes and dyslipidemia, inflammation …

BACKGROUND: The relation between measures of oxidation of lipid particles and
cardiovascular disease has not been extensively investigated prospectively on a population …

Objectives: To evaluate the importance of different autoantibodies against modified low-
density lipoprotein (LDL) in patients with coronary artery disease (CAD). Background …

Atherosclerosis is a chronic inflammatory process of the arterial wall associated with
systemic and local immune responses to various antigens, oxidized low‐density lipoprotein …

Oxidative modification of LDL has been proposed as an early and crucial step in the
development of atherosclerosis, and antibodies against such modified LDL are found in both …